1. Market Overview of NGS-based RNA-seq
1.1 NGS-based RNA-seq Market Overview
1.1.1 NGS-based RNA-seq Product Scope
1.1.2 Market Status and Outlook
1.2 NGS-based RNA-seq Market Size by Regions: 2015 VS 2021 VS 2026
1.3 NGS-based RNA-seq Historic Market Size by Regions (2015-2020)
1.4 NGS-based RNA-seq Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact NGS-based RNA-seq Sales Market by Type (2015-2026)
2.1 Global NGS-based RNA-seq Historic Market Size by Type (2015-2020)
2.2 Global NGS-based RNA-seq Forecasted Market Size by Type (2021-2026)
2.3 Sample Preparation
2.4 Sample Preparation
2.5 by Method
2.6 Sequencing Platforms & Consumables for RNA-Seq
2.7 RNA Sequencing Services
2.8 Data Analysis
2.9 Storage
2.10 and Management
3. Covid-19 Impact NGS-based RNA-seq Sales Market by Application (2015-2026)
3.1 Global NGS-based RNA-seq Historic Market Size by Application (2015-2020)
3.2 Global NGS-based RNA-seq Forecasted Market Size by Application (2021-2026)
3.3 De Novo Transcriptome Assembly
3.4 Expression Profiling Analysis
3.5 Variant Calling and Transcriptome Epigenetics
3.6 Small RNA Sequencing
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global NGS-based RNA-seq Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global NGS-based RNA-seq Revenue Market Share by Manufacturers (2015-2020)
4.3 Global NGS-based RNA-seq Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in NGS-based RNA-seq Business
5.1 Illumina
5.1.1 Illumina Company Profile
5.1.2 Illumina NGS-based RNA-seq Product Specification
5.1.3 Illumina NGS-based RNA-seq Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Company Profile
5.2.2 Thermo Fisher Scientific NGS-based RNA-seq Product Specification
5.2.3 Thermo Fisher Scientific NGS-based RNA-seq Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Pacific Biosciences of California
5.3.1 Pacific Biosciences of California Company Profile
5.3.2 Pacific Biosciences of California NGS-based RNA-seq Product Specification
5.3.3 Pacific Biosciences of California NGS-based RNA-seq Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 QIAGEN
5.4.1 QIAGEN Company Profile
5.4.2 QIAGEN NGS-based RNA-seq Product Specification
5.4.3 QIAGEN NGS-based RNA-seq Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 BGI
5.5.1 BGI Company Profile
5.5.2 BGI NGS-based RNA-seq Product Specification
5.5.3 BGI NGS-based RNA-seq Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Oxford Nanopore Technologies
5.6.1 Oxford Nanopore Technologies Company Profile
5.6.2 Oxford Nanopore Technologies NGS-based RNA-seq Product Specification
5.6.3 Oxford Nanopore Technologies NGS-based RNA-seq Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 PerkinElmer
5.7.1 PerkinElmer Company Profile
5.7.2 PerkinElmer NGS-based RNA-seq Product Specification
5.7.3 PerkinElmer NGS-based RNA-seq Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 GATC Biotech
5.8.1 GATC Biotech Company Profile
5.8.2 GATC Biotech NGS-based RNA-seq Product Specification
5.8.3 GATC Biotech NGS-based RNA-seq Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Agilent Technologies
5.9.1 Agilent Technologies Company Profile
5.9.2 Agilent Technologies NGS-based RNA-seq Product Specification
5.9.3 Agilent Technologies NGS-based RNA-seq Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Roche
5.10.1 Roche Company Profile
5.10.2 Roche NGS-based RNA-seq Product Specification
5.10.3 Roche NGS-based RNA-seq Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Macrogen
5.11.1 Macrogen Company Profile
5.11.2 Macrogen NGS-based RNA-seq Product Specification
5.11.3 Macrogen NGS-based RNA-seq Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Eurofins Scientific
5.12.1 Eurofins Scientific Company Profile
5.12.2 Eurofins Scientific NGS-based RNA-seq Product Specification
5.12.3 Eurofins Scientific NGS-based RNA-seq Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America NGS-based RNA-seq Market Size (2015-2026)
6.2 North America NGS-based RNA-seq Key Players in North America (2015-2020)
6.3 North America NGS-based RNA-seq Market Size by Type (2015-2020)
6.4 North America NGS-based RNA-seq Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia NGS-based RNA-seq Market Size (2015-2026)
7.2 East Asia NGS-based RNA-seq Key Players in North America (2015-2020)
7.3 East Asia NGS-based RNA-seq Market Size by Type (2015-2020)
7.4 East Asia NGS-based RNA-seq Market Size by Application (2015-2020)
8. Europe
8.1 Europe NGS-based RNA-seq Market Size (2015-2026)
8.2 Europe NGS-based RNA-seq Key Players in North America (2015-2020)
8.3 Europe NGS-based RNA-seq Market Size by Type (2015-2020)
8.4 Europe NGS-based RNA-seq Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia NGS-based RNA-seq Market Size (2015-2026)
9.2 South Asia NGS-based RNA-seq Key Players in North America (2015-2020)
9.3 South Asia NGS-based RNA-seq Market Size by Type (2015-2020)
9.4 South Asia NGS-based RNA-seq Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia NGS-based RNA-seq Market Size (2015-2026)
10.2 Southeast Asia NGS-based RNA-seq Key Players in North America (2015-2020)
10.3 Southeast Asia NGS-based RNA-seq Market Size by Type (2015-2020)
10.4 Southeast Asia NGS-based RNA-seq Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East NGS-based RNA-seq Market Size (2015-2026)
11.2 Middle East NGS-based RNA-seq Key Players in North America (2015-2020)
11.3 Middle East NGS-based RNA-seq Market Size by Type (2015-2020)
11.4 Middle East NGS-based RNA-seq Market Size by Application (2015-2020)
12. Africa
12.1 Africa NGS-based RNA-seq Market Size (2015-2026)
12.2 Africa NGS-based RNA-seq Key Players in North America (2015-2020)
12.3 Africa NGS-based RNA-seq Market Size by Type (2015-2020)
12.4 Africa NGS-based RNA-seq Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania NGS-based RNA-seq Market Size (2015-2026)
13.2 Oceania NGS-based RNA-seq Key Players in North America (2015-2020)
13.3 Oceania NGS-based RNA-seq Market Size by Type (2015-2020)
13.4 Oceania NGS-based RNA-seq Market Size by Application (2015-2020)
14. South America
14.1 South America NGS-based RNA-seq Market Size (2015-2026)
14.2 South America NGS-based RNA-seq Key Players in North America (2015-2020)
14.3 South America NGS-based RNA-seq Market Size by Type (2015-2020)
14.4 South America NGS-based RNA-seq Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World NGS-based RNA-seq Market Size (2015-2026)
15.2 Rest of the World NGS-based RNA-seq Key Players in North America (2015-2020)
15.3 Rest of the World NGS-based RNA-seq Market Size by Type (2015-2020)
15.4 Rest of the World NGS-based RNA-seq Market Size by Application (2015-2020)
16 NGS-based RNA-seq Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.